Clinical Trial Update: Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM) [EARLY_Phase 1]

View source ↗

Summary

An early-phase exploratory trial evaluating immune modulation by VEGF blockade in glioblastoma multiforme; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Glioblastoma Multiforme | EARLY_Phase 1 | Status: COMPLETED